FDA NEWS RELEASE For Immediate Release: Jan. 30, 2012Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.govConsumer Inquiries: 888-INFO-FDA FDA approves new treatment for most common type of skin cancer Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The…
